Gilead Sciences
GILD
#129
Rank
A$227.67 B
Marketcap
A$183.49
Share price
-1.14%
Change (1 day)
29.60%
Change (1 year)

Gilead Sciences (GILD) - Total debt

Total debt on the balance sheet as of September 2025 : A$37.75 Billion

According to Gilead Sciences's latest financial reports the company's total debt is A$37.75 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Gilead Sciences - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$42.94 B17.09%
2023-12-31A$36.67 B-1.08%
2022-12-31A$37.07 B0.69%
2021-12-31A$36.82 B-9.84%
2020-12-31A$40.83 B16.26%
2019-12-31A$35.12 B-9.43%
2018-12-31A$38.78 B-9.73%
2017-12-31A$42.96 B17.55%
2016-12-31A$36.54 B20.73%
2015-12-31A$30.27 B99.75%
2014-12-31A$15.15 B103.73%
2013-12-31A$7.43 B-5.99%
2012-12-31A$7.91 B6.67%
2011-12-31A$7.41 B116.25%
2010-12-31A$3.43 B146.87%
2009-12-31A$1.38 B-15.49%
2008-12-31A$1.64 B9.6%
2007-12-31A$1.50 B-16.14%
2006-12-31A$1.78 B335.2%
2005-12-31A$0.41 B76571.55%
2004-12-31A$0.53 M-99.88%
2003-12-31A$0.46 B-56.03%
2002-12-31A$1.05 B114.15%
2001-12-31A$0.49 B8.1%
2000-12-31A$0.45 B241.02%
1999-12-31A$0.13 B-19.23%
1998-12-31A$0.16 B3274.94%
1997-12-31A$4.91 M-39.97%
1996-12-31A$8.18 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
A$82.62 B 118.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$2.77 B-92.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$104.05 B 175.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$3.89 B-89.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$9.97 B-73.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$92.10 B 143.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$69.31 B 83.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$64.34 B 70.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$62.62 B 65.89%๐Ÿ‡บ๐Ÿ‡ธ USA